Endometrial cancer (patient information)

Revision as of 19:17, 15 July 2009 by Kogando (talk | contribs)
Jump to navigation Jump to search

For the WikiDoc page for this topic, click here

WikiDoc Resources for Endometrial cancer (patient information)

Articles

Most recent articles on Endometrial cancer (patient information)

Most cited articles on Endometrial cancer (patient information)

Review articles on Endometrial cancer (patient information)

Articles on Endometrial cancer (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Endometrial cancer (patient information)

Images of Endometrial cancer (patient information)

Photos of Endometrial cancer (patient information)

Podcasts & MP3s on Endometrial cancer (patient information)

Videos on Endometrial cancer (patient information)

Evidence Based Medicine

Cochrane Collaboration on Endometrial cancer (patient information)

Bandolier on Endometrial cancer (patient information)

TRIP on Endometrial cancer (patient information)

Clinical Trials

Ongoing Trials on Endometrial cancer (patient information) at Clinical Trials.gov

Trial results on Endometrial cancer (patient information)

Clinical Trials on Endometrial cancer (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Endometrial cancer (patient information)

NICE Guidance on Endometrial cancer (patient information)

NHS PRODIGY Guidance

FDA on Endometrial cancer (patient information)

CDC on Endometrial cancer (patient information)

Books

Books on Endometrial cancer (patient information)

News

Endometrial cancer (patient information) in the news

Be alerted to news on Endometrial cancer (patient information)

News trends on Endometrial cancer (patient information)

Commentary

Blogs on Endometrial cancer (patient information)

Definitions

Definitions of Endometrial cancer (patient information)

Patient Resources / Community

Patient resources on Endometrial cancer (patient information)

Discussion groups on Endometrial cancer (patient information)

Patient Handouts on Endometrial cancer (patient information)

Directions to Hospitals Treating Endometrial cancer (patient information)

Risk calculators and risk factors for Endometrial cancer (patient information)

Healthcare Provider Resources

Symptoms of Endometrial cancer (patient information)

Causes & Risk Factors for Endometrial cancer (patient information)

Diagnostic studies for Endometrial cancer (patient information)

Treatment of Endometrial cancer (patient information)

Continuing Medical Education (CME)

CME Programs on Endometrial cancer (patient information)

International

Endometrial cancer (patient information) en Espanol

Endometrial cancer (patient information) en Francais

Business

Endometrial cancer (patient information) in the Marketplace

Patents on Endometrial cancer (patient information)

Experimental / Informatics

List of terms related to Endometrial cancer (patient information)

Editor-in-Chief:

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

What is endometrial cancer?

Endometrial cancer is a cancer that forms in the tissue lining the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a baby grows). Most endometrial carcinomas are cancers of the cells that form glands in the endometrium. These are called adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids).

The most common type of endometrial cancer is called endometrioid adenocarcinoma. Other rare types of endometrial carcinomas include squamous cell and undifferentiated. Doctors sometimes divide endometrial carcinoma into 2 types based on their outlook and underlying causes. "Type 1" cancers are thought to be caused by excess estrogen. They are usually not very aggressive and are slow to spread to other tissues.

A small number of endometrial cancers are "type 2." Experts aren't sure what causes type 2 cancers, but the type 2 cancers don't seem to be caused by too much estrogen. Because type 2 cancers are more likely to grow and spread outside of the uterus, they have a poorer outlook than type 1 cancers. Doctors tend to treat these cancers more aggressively.

How do I know if I have endometrial cancer and what are the symptoms of endometrial cancer?

Who is at risk for endometrial cancer?

Endometrial cancer usually occurs in women after menopause, and affects more white women than black women. Black women diagnosed with endometrial cancer are more likely to have more advanced disease at diagnosis, and are more likely to die from endometrial cancer than white women.

Some of the risk factors for endometrial cancer are:

Estrogen Exposure

Estrogen exposure through estrogen-only hormone replacement therapy. A combination estrogen-progestin replacement therapy in post menopausal women, however, has not been shown to increase the risk of endometrial cancer.

Beginning to have menstrual periods at an early age also increases the number of years the body is exposed to estrogen and increases a woman's risk of endometrial cancer. Similarly, women who reach menopause at an older age are exposed to estrogen for a longer time and have an increased risk of endometrial cancer.

Never being pregnant is also a risk factor for endometrial cancer. Because estrogen levels are lower during pregnancy, women who have never been pregnant are exposed to estrogen for a longer time than women who have been pregnant. This increases the risk of endometrial cancer.

Tamoxifen

Tamoxifen is one of a group of drugs called selective estrogen receptor modulators, or SERMs. Tamoxifen is used to prevent breast cancer in women who are at high risk for the disease, but it increases the risk of endometrial cancer. This risk is greater in postmenopausal women.

Another drug in the SERM group, raloxifene, is used to prevent bone weakness in postmenopausal women and has not been shown to increase the risk of endometrial cancer.

Inherited risk

Hereditary nonpolyposis colon cancer (HNPCC) syndrome is an inherited disorder caused by changes in certain genes. Women who have HNPCC syndrome have a much higher risk of developing endometrial cancer than women who do not have HNPCC syndrome.

Polycystic ovary syndrome

Women who have polycystic ovary syndrome (a disorder of the hormones made by the ovaries) have an increased risk of endometrial cancer.

Body fat

Obesity increases the risk of endometrial cancer. This may be because obesity is related to other risk factors such as estrogen levels, polycystic ovary syndrome, lack of physical activity, and a diet that is high in saturated fats.

It is not known if losing weight decreases the risk of endometrial cancer.

How to know you have endometrial cancer?

When to seek urgent medical care

Treatment options

Diseases with similar symptoms

Where to find medical care for endometrial cancer

Directions to Hospitals Treating endometrial cancer

Prevention of endometrial cancer

What to expect (Outlook/Prognosis)

Sources

Template:SIB Template:WH Template:WS